Small For Gestational Age
📧 Sign up to get email alerts when something new happens for Small For Gestational Age.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation [Phase 4]
Completed Phase 4 trial evaluating growth hormone treatment in children diagnosed with intrauterine growth restriction, including cases desc…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Efficacy on Height in SGA Children Treated With Growth Hormone [Phase 3]
Phase 3 trial update evaluating growth hormone therapy (somatropin) for increasing height in children who were small for gestational age.
-
CLINICAL_TRIALS research · 2016-10-14Clinical Trial Update: Effect of Insulin Sensitization on IGF-1 Response to Growth Hormone in SGA Children [NA]
This clinical trial update examines whether improving insulin sensitivity alters the IGF-1 response to growth hormone therapy in children bo…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Community-based Screening and Treatment of Malaria in Pregnancy: a Cluster-randomized Trial [NA]
This document reports the completion of a cluster-randomized trial evaluating community-based screening and treatment of malaria in pregnanc…
-
FDA approval · 2016-06-23FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)
FDA approves a supplemental application for Norditropin (somatropin) from Novo Nordisk, indicating changes to labeling and/or indications.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-03-17FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for Nutropin AQ Nuspin 10 (somatropin) by Genentech, Inc.
-
FDA approval · 2016-02-26FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Nutropin AQ Nuspin 10 (somatropin) from Genentech, Inc., updating/expanding the product’s approv…
-
CLINICAL_TRIALS research · 2016-02-12Clinical Trial Update: A Pharmaco-epidemiological Study of Short Patients Born Small for Gestational Age (SGA), Treated With Saizen® (Recombinant Somatropin)
This clinical trial update summarizes a pharmaco-epidemiological study of infants born small for gestational age treated with Saizen (recomb…
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction [Phase 4]
A Phase 4 trial evaluating growth hormone treatment in children born small for gestational age has been completed.
-
CLINICAL_TRIALS research · 2015-08-04Clinical Trial Update: Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.
Clinical trial update about antenatal detection of fetal growth restriction and its relation to stillbirth rates; current status is unknown.
-
FDA approval · 2015-06-12FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for ZOMACTON (somatropin) from Ferring Pharmaceuticals, likely to update labeling or expand indicati…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants [Phase 3]
A Phase 3 trial evaluating glutamine supplementation to prevent death or infection in extremely premature infants has completed.
-
CLINICAL_TRIALS research · 2015-06-08Clinical Trial Update: Growth Observational Study
Update on the NICHD Neonatal Research Network growth observational study; the study has completed and tracks growth outcomes in newborns, in…
-
FDA approval · 2015-05-26FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Nutropin AQ Nuspin 10 (somatropin) from Genentech, adding/confirming a formulation strength unde…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Epigenetic Markers of B-Cell Function in Low Birth Weight Infants
A completed trial examining epigenetic markers related to B-cell function in low birth weight infants and how early growth status may influe…
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Safety and Efficacy of Long-term Somatropin Treatment in Children
Clinical trial update reporting long-term safety and efficacy of somatropin treatment in pediatric patients with growth-related conditions.
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: A Multi-Site Study of Music Therapy Interventions on Vitals, Feeding and Sleep in Premature Infants [NA]
Completed, multi-site clinical trial evaluating music therapy interventions on vitals, feeding, and sleep in premature infants, including th…
-
FDA approval · 2015-01-23FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Norditropin (somatropin) from Novo Nordisk, resulting in an approved supplemental indication/lab…
-
CLINICAL_TRIALS research · 2014-12-29Clinical Trial Update: Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae [Phase 2]
A Phase 2 clinical trial is evaluating early growth hormone treatment in infants born small for gestational age to prevent irreversible neur…
-
CLINICAL_TRIALS research · 2014-12-02Clinical Trial Update: Constructing an Insulin-Like Growth Factor-based Prediction Model
The trial update describes efforts to construct an insulin-like growth factor–based predictive model for growth disorders (Growth Hormone De…
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Genotropin Treatment In Very Young Children Born Small For Gestational Age [Phase 3]
The document reports the completion and posted results of a Phase 3 trial evaluating Genotropin (somatropin) in very young children born sma…
-
FDA approval · 2014-07-30FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humatrope (somatropin) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Assessing the Impact of Smoke-free Legislation on Perinatal Health in the Netherlands
A completed clinical trial from the University of Edinburgh evaluated how smoke-free legislation in the Netherlands affects perinatal outcom…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone
This completed trial evaluated the usability and tolerability of the Norditropin NordiFlex injection device in children with growth hormone …
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector
A completed clinical trial evaluated the convenience and adherence of the Easypod electronic self-injector for growth hormone therapy in con…